Eye tech com­pa­ny snags first-ever ap­proval for spray to di­late pupils for di­ag­nos­tic ex­ams

Eye tech­nol­o­gy com­pa­ny Eye­n­ovia snagged its first ever FDA ap­proval Mon­day with the green light for My­d­com­bi, which the com­pa­ny calls the first ap­proved oph­thalmic spray for my­dri­a­sis, or di­lat­ed pupils.

My­d­com­bi, a spray made up of tropi­camide and phenyle­phrine hy­drochlo­ride, is de­signed to di­late the pupil in or­der to make eye ex­ams more ef­fi­cient and to help keep pupils di­lat­ed dur­ing cataract surgery. Eye­n­ovia says it’s al­so the first fixed-dose com­bi­na­tion of tropi­camide and phenyle­phrine in the Unit­ed States.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.